Stock Events

Stock Events

Xilio Therapeutics (XLO) Q3 2024 Earnings

8AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.73

-0.48

-0.24

0

Details

Expected EPS

-0.23

Actual EPS

-0.24

Surprise EPS

-0.01

Surprise Percent

+4.35%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.24 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.